All topics

Research and clinical trials

Clinical trials, biomarkers, microbiome, genetics, AI, basic science, and emerging IBD research.

Page 14 of 14 · 627 articles

Amelenodor by AbbVie for Crohn’s Disease (Regional Enteritis): Likelihood of Approval
pharmaceutical-technology.com

Amelenodor by AbbVie for Crohn’s Disease (Regional Enteritis): Likelihood of Approval

This notes a new oral investigational drug (Amelenodor/NX-13) in Phase I for Crohn’s and ulcerative colitis and highlights industry predictions about its chances of advancing. People with IBD may want to know about...

Read Summary